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Background: Temporal artery biopsy (TAB) is a surgical procedure with a low positive yield. The purpose of 
this study is to determine which variables are the most important in the giant cell arteritis (GCA) diagnosis. The 
objective of this evaluation is to improve the percentage of positive temporal artery biopsy and if possible, avoid 
the biopsy in some cases. 
Material and Methods: A retrospective clinical study consisted of 90 patients who had undergone TAB at the Río 
Hortega Hospital (Spain) from January 2009 to December 2016. Clinical findings, erythrocyte sedimentation rates 
(ESR) and other laboratory parameters, American College of Rheumatology (ACR) criteria for GCA score and 
biopsy results were recorded. 
Results: Nineteen (21.1%) biopsies were positive for GCA. The mean age in positive TAB was 78.6 years old (SD 
7.93), and 73.7% were female. Presence of temporal headache (p = 0.003), jaw claudication (p = 0.001), abnormal 
artery exploration (p = 0.023), elevated erythrocyte sedimentation rate (p = 0.035), CRP (p = 0.018) and platelets 
(p = 0.042), were significantly associated with GCA. Multivariate logistic regression revealed that the best predic-
tors for the diagnosis of GCA are headache and jaw claudication, adjusted by sex, age, and temporal exploration.
Conclusions: TAB has benefit only for patients who score a 2 or 3 on the ACR criteria for GCA without biopsy. 
These findings highlight the need for a better diagnostic strategy for patients with suspected temporal arteritis.
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Introduction
Giant cell arteritis (GCA), also known as temporal or 
granulomatous arteritis, described by Horton in 1932, 
is a relatively common form of blood vessel inflamma-
tion, which usually affects people over the age of 50, 
with peak incidences occurring between the ages of 
70 and 80 (1). GCA is a systemic vasculitis that affects 
large and medium sized arteries, and is most prevalent 
in the white population of European origin (2). Women 
are two to three times more susceptible. The inflamma-
tory process leads to vessel scarring, narrowing, severe 
stenosis, and eventually occlusion (3).
GCA typically causes headaches, tenderness over tem-
poral arteries, jaw claudication (pain with chewing), 
low-grade fever and systemic upset, but can also be as-
sociated with sudden and irreversible sight loss. GCA 
often progresses rapidly and, if left untreated, leads 
to severe pain, permanent visual loss, stroke and, in 
some cases, death. There is an entity called occult GCA 
which occurs about 20% of the time, and is defined as 
ocular involvement with absence of systemic symptoms 
or signs.
Jaw claudication consists in the appearance of pain and 
tiredness of facial musculature secondary to chewing 
which goes down with repose. It is due to affectation of 
the internal maxillary artery and facial artery as well 
as its branches. This affectation is the most common 
characteristic of GCA, although it is only present in less 
than half of the cases based on different studies (4). The 
importance of this symptom and temporal headache, is 
that it can be the reason to consult an oral and maxil-
lofacial surgeon. In these cases, we will have to conduct 
a differential diagnosis with either temporomandibular 
joint dysfunction or myofascial pain syndrome as well 
as investigate the presence of other symptoms, signs or 
analytical alterations which can lead us to suspect that 
we are encountering a giant cell arteritis case.
Temporal artery biopsy (TAB) is the current gold stan-
dard test for establishing the diagnosis, with a high 
specificity but low sensitivity. It can be misleading in 
a significant number of cases. Up to 44% of patients 
with clinical features of GCA have a negative biopsy 
(5). There are many reasons for this, including the ad-
equacy of the specimen obtained, the duration of gluco-
corticoid treatment prior to biopsy and the presence of 
skip lesions (intermittent). However, it is also important 
to avoid treating those without the condition, because 
there is a very high incidence of side effects associated 
with long-term glucocorticoid therapy. Ultrasound and 
other imaging techniques are emerging as alternative 
tests to biopsy but have not been widely accepted. 
Recent literature suggests that there is now enough evi-
dence that TAB does not change the management of 
GCA and that the use of imaging modalities, such as 
ultrasound scan, color doppler sonography and cranial 
magnetic resonance imaging (MRI) may be sufficient 
to confirm the diagnosis. Gallium-67 SPECT scintigra-
phy may be useful in the diagnosis of the disease too, al-
though further studies are needed to confirm this data.
In summary, the management of GCA requires a bal-
ance between ensuring that patients with GCA are di-
agnosed and treated promptly (to avoid complications 
such as sight loss) and avoiding the burden of unnec-
essary steroid treatment in people without GCA. Glu-
cocorticoids are the mainstay of treatment and once 
administered rapid improvement of all clinical manifes-
tations following treatment initiation is characteristic. 
Thus therapy should not be delayed pending temporal 
artery biopsy which should be performed as soon as 
possible. The average duration of treatment is two to 
three years, but some may develop disease-related or 
treatment-related complications (osteoporosis, diabe-
tes, hypertension, etc.); careful follow-up and periodic 
laboratory evaluations with ESR and CRP are required. 
Prevention, screening, and management of corticoste-
roid-induced complications are essentials. Failure to re-
spond or development of steroid-related adverse effects 
are indications to consider immunosuppression with 
methotrexate. 
GCA may result in fatal complications; the major causes 
of mortality have been vascular: stroke, coronary artery 
events, rupture of thoracic aortic aneurysms, and aortic 
dissection. 
The purpose of this study is to determine which vari-
ables are the most important in the giant cell arteritis 
(GCA) diagnosis.
Material and Methods
The design of this study is observational and descrip-
tive, based on diagnostic tests with a benchmark test 
(gold standard).
A retrospective clinical study consisted of patients who 
had undergone TAB at the Río Hortega Hospital (De-
partment of Oral and Maxillofacial Surgery, Valladolid, 
Spain) from January 2009 to December 2016. The same 
investigator extracted data from all records and col-
lected detailed information using a standardized form. 
Demographic, laboratory and clinical data were col-
lected. The variables recorded were: age, sex, presence 
or absence of temporal headache, jaw claudication, vi-
sual disturbance (amaurosis fugax, vision loss, diplopia 
or eye pain), fever, positive biopsy, abnormal temporal 
artery exploration (decreased pulse or tenderness, pain, 
thickening and or presence of nodules), previous diag-
nosis of polymyalgia rheumatica (PMR), and levels of 
ESR, C-reactive protein (CRP), hemoglobin and plate-
lets. Anemia was defined as  hemoglobin level of less 
than13 g/dl in men and 12 g/dl in women.  
All TAB were performed using local anaesthesia and 
the size of specimens were between 1-2 cm in all pa-
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tients (Fig. 1). Recent studies suggest that a post-fixa-
tion superficial temporal artery biopsy length of 7 to 10 
mm is adequate for diagnosing giant cell arteritis (6). 
Histopathologically (Fig. 2), two patterns were consid-
ered diagnostic of giant cell arteritis: those with inflam-
mation of the vessel wall (active arteritis) and those with 
post-inflammatory alterations (healed arteritis).
All data was entered into Microsoft Excel and statistical 
analysis was performed using SPSS Version 15.0 (SPSS 
Inc, 1989-2006). Categorical variables are expressed as 
a percentage (%) and quantitative variables as mean +/- 
standard deviation (SD).
Statistical analysis was performed using χ2 analysis or 
Fisher ś exact test for categorical variables, Student t 
test for continuous variables, and categorical regression 
analysis for multivariate analysis. A p value less than 
0.05 defined statistical significance.
Sensitivitiy, specificity, predictive values, and likeli-
hood ratios were calculated for the association of the 
various clinical and analytical findings and the presence 
of a positive biopsy result.
Results
A total of 90 TAB were performed on 90 patients in our 
hospital from 2009 to 2016. The mean age was 77.28 
years old (SD 9.06), 62.2 % were performed on females 
and 37.8 % on males. Of the 90 TAB performed, only 19 
(21.1%) specimens were reported as positive for GCA, 
the remaining 71 (78.9 %) specimens reported as nega-
tive for GCA. The mean age in positive TAB was 78.6 
years old (SD 7.93), and 73.7% were female. 
The temporal cephalea was the most frequent symptom 
in this study, occurring in 68.4% of positive biopsies 
(statistically significant association, p= 0.003), followed 
by jaw claudication (42.1%, p = 0.001) and abnormal ex-
ploration (42.1%, p = 0.023). 
In our study, the mean ESR value in positive TAB cases 
was 69.16 mm/h (SD 28.9), elevated value was signifi-
cantly associated with GCA (p = 0.035) and mean CRP 
value was 108.79 mg/l (SD 64.4, p =0.018). Therefore, 
100% of the positive TAB had abnormal levels of ESR 
and CRP. 
Permanent visual loss has been reported to occur in 
as high as 15-20% of these patients, making early and 
correct diagnosis critical (2). In our case, 15.6% of the 
studied patients had visual alterations and only 26.3% 
of them had a positive result in the biopsy. 
In the present study, positive TAB is also correlated with 
a lower hemoglobin level (73.7% of patients had anemia) 
but is not significantly associated with a positive TAB. 
However there is a statistically significant association 
with higher platelet count (57.9% of patients, p = 0.042).
Before biopsy, 25 of the 90 (27.8%) patients met ACR 
criteria for GCA with a score of 3 or more. Thirteen 
(52%) of these had a positive biopsy. Thirteen (14.4%) 
patients scored ≤ 1 before biopsy, incapable of meeting 
ACR criteria for GCA; only one (5.3%) of these biopsies 
was positive. Fifty-two (57.8%) patients scored 2 before 
biopsy, but only 5 (9.6%) had a positive biopsy (Table 1). 
Out of the total positive biopsies, 68.4% met 3 or more 
criteria before the biopsy was performed. In this study, 
a score  ≥ 3 criteria has a sensitivity of 68.42% and a 
specificity of 83.1% for GCA. 
If we assess the variables gathered in our study, we can 
observe that having more than 6 variables altered with-
in the 12 studied, the sensitive would be 69,42% and the 
specificity would be 73,24%.
Fig. 2. A. Anatomic pathology image (H/E 10 x) of a temporal giant 
cell arteritis with inflammation of the vessel wall (active arteritis). 
Adventitious and subintimal fibrosis thickening with decreased light. 
Inflammatory infiltrates in arterial wall. B. Fragmentation and dis-
ruption of the internal elastic lamina with multinucleated giant cells 
(elastic stain).
Fig. 1. Intraoperative image of a temporal artery biopsy (left side). 
The most symptomatic artery is usually selected for biopsy and is 
most likely to show evidence of pathological findings. Size of speci-
men >1 cm.
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Multivariate logistic regression revealed that the best 
predictors for the diagnosis of GCA are headache (OR 
6,908. 95% CI 1,716-27,807. p = 0.007) and jaw clau-
dication (OR 9,127. 95% CI 1,957-42,578. p = 0.005), 
adjusted by sex (female), age (>78 years) and temporal 
exploration (abnormal). 
Discussion
The percentage of positive temporal artery biopsy is 
low, of the 90 TAB performed, only 19 (21.1%) speci-
mens were reported as positive for GCA. However, this 
appears to be consistent with recently published litera-
ture reporting similarly low positive TAB specimen 
rates of 7-35% (7,8,9). The mean age in positive TAB 
was 78.6 years old (SD 7.93), and 73.7% were female, 
similar to other studies (with a peak incidence between 
the ages of 70 and 80, and more frequent in women).
In our study, the temporal cephalea was the most fre-
quent symptom in positives biopsies (68.4%), followed 
by jaw claudication and abnormal exploration. In the 
majority of studies, headache especially located at the 
temples is the most common symptom (60-90%) and 
jaw claudication is the most specific symptom (2,9,10). 
The two most important labs to order to help make the 
diagnosis are the ESR and CRP. If they are elevated 
they may indicate systemic inflammation. Elevation 
may also be from other causes like infection, malig-
nancy, autoimmune diseases, etc. The combination of 
ESR and CRP is 97% specific for the diagnosis of GCA 
according to Hayreh et al. CRP was 100% sensitive for 
detection of GCA and ESR was 92% (11). In our study, 
100% of the positive TAB had abnormal levels of ESR 
and CRP, however they can also be normal. This sup-
ports the use of ESR and CRP in the initial diagnosis 
of GCA.
Polymyalgia rheumatica (PMR) is a clinical syndrome 
of an unknown etiology, characterized by pain and stiff-
ness, especially in shoulders, neck and hip areas. PMR 
may be isolated or associated with GCA. In both condi-
tions the erythrocyte sedimentation rate (ESR) and the 
C-reactive protein (CRP) are elevated, and anemia and 
thrombocytosis may occur. Five to 15% of PMR pa-
tients will be diagnosed with GCA, and 50% of GCA 
patients will have PMR symptoms (12). In our job, yet 
only 15.8% of the patients with positive biopsy had a 
previous PMR diagnosis. 
The 1990 American College of Rheumatology (ACR) 
classification criteria for GCA are based on the follow-
ing: 
-Aged at least 50 years old.
-A new headache. 
-Temporal artery abnormality on physical examination 
(such as tenderness to palpation or decreased pulsation). 
-Elevated erythrocyte sedimentation rate (ESR) typi-
cally ≥  50 mm/h.
-Abnormal temporal artery biopsy (TAB) showing vas-
culitis with mononuclear cell or granulomatous inflam-
mation, usually with giant cells.
The presence of at least three of the five criteria is need-
ed for a positive diagnosis, which yields a sensitivity 
of 93-94% and a specificity of 91%, although unusual 
presentations of GCA can be missed. Out of the total 
positive biopsies, 68.4% met 3 or more criteria before 
the biopsy was performed. Therefore, like in other stud-
ies (1), TAB has only benefited patients who score a 2 or 
3 on the ACR criteria for GCA without biopsy. 
Since 1932 the conventional gold standard investigation 
for GCA has been a TAB, showing vasculitis (specific-
ity 100% and sensitivity 15-40%), (7).  The character-
istic finding of histiocytes, epithelioid and giant cells at 
the intimal-medial junction is useful in diagnosis,  but 
not always present (e.g. giant cells were found in 75% of 
positive biopsies in a recent series). Giant cell arteritis 
affects the vessels in segments, therefore areas of vas-
culitis may be missed and the histological examination 
is normal in 10-30% of GCA patients (12). A contralat-
eral biopsy should be considered after a negative initial 
biopsy if clinical suspicion is high for GCA. However, 
a negative biopsy can be useful to prevent unnecessary 
courses of steroids.
TAB is a surgical procedure with a low positive yield. 
Previous studies have also mentioned the use of algo-
rithms and incorporating the use of ultrasound scan in 
these algorithms alongside TAB to help improve yield 
rates of TAB (1). Ultrasound has the highest resolution 
of all imaging techniques used for the diagnosis of vas-
culitis.  Karassa et al. performed a meta-analysis show-
ing that sensitivity of temporal artery duplex ultrasound 
was 87% and specificity 96% (13). 
In conclusion, these findings highlight the need for a bet-
ter diagnostic strategy for patients with suspected tempo-
ral arteritis. Henceforth, more prospective studies which 
included the studied variables, the ACR criteria and dif-
ferent imaging test must be done in order to improve the 
percentage of positivity in temporal artery biopsies.
ACR Frequency Percentage
Criteria 1 13 14,4
 2 52 57,8
 3 16 17,8
 4 9 10,0
 Total 90 100,0
Table 1. Data table showing the patients distribution accord-
ing to the number of ACR criteria before performing a tem-
poral artery biopsy. 
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